OFSA3 Relative Valuation - Ouro Fino Saude Animal Participacoes SA

Watchlist Manager

Watchlist

Price: 27.39 BRL 3.01% Market Closed

Market Cap: R$1.5B

	Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3	BR
	Banco Macro SA NYSE:BMA	AR

Multiples-Based Value

The Multiples-Based Value of one OFSA3 stock under the Base Case scenario is 38.46 BRL. Compared to the current market price of 27.39 BRL, Ouro Fino Saude Animal Participacoes SA is Undervalued by 29%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

OFSA3 Multiples-Based Value

Base Case

Undervaluation 29%

Multiples-Based Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
BR		Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3	1.5B BRL	1.2	6.6	6.1	7.1
US		Eli Lilly and Co NYSE:LLY	847.5B USD	13	41.1	27.7	29.6
US		Johnson & Johnson NYSE:JNJ	576.1B USD	6.1	21.5	14.9	18.4
CH		Roche Holding AG SIX:ROG	248.4B CHF	4	19.3	11.5	12.9
US		Merck & Co Inc NYSE:MRK	294.3B USD	4.5	16.1	10	12.1
UK		AstraZeneca PLC LSE:AZN	214.5B GBP	5.1	29	16.1	22.7
CH		Novartis AG SIX:NOVN	229.3B CHF	5.2	21.1	13.1	16.8
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
DK		Novo Nordisk A/S CSE:NOVO B	1T DKK	3.3	10	7.5	8.8
US		Pfizer Inc NYSE:PFE	156.8B USD	2.5	20.2	7.7	10.3
US		Bristol-Myers Squibb Co NYSE:BMY	119.6B USD	2.5	17	7.2	8.8

				Revenue Growth	P/S to Growth
BR		Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3	Average P/S: 13.6 1.2	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	13	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.1	6%	1
CH		Roche Holding AG SIX:ROG	4	4%	1
US		Merck & Co Inc NYSE:MRK	4.5	5%	0.9
UK		AstraZeneca PLC LSE:AZN	5.1	7%	0.7
CH		Novartis AG SIX:NOVN	5.2	5%	1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.3	2%	1.7
US		Pfizer Inc NYSE:PFE	2.5	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
BR		Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3	Average P/E: 20.2 6.6	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	41.1	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.5	7%	3.1
CH		Roche Holding AG SIX:ROG	19.3	14%	1.4
US		Merck & Co Inc NYSE:MRK	16.1	14%	1.2
UK		AstraZeneca PLC LSE:AZN	29	26%	1.1
CH		Novartis AG SIX:NOVN	21.1	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10	1%	10
US		Pfizer Inc NYSE:PFE	20.2	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	17	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
BR		Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3	Average EV/EBITDA: 45.2 6.1	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	27.7	22%	1.3
US		Johnson & Johnson NYSE:JNJ	14.9	2%	7.5
CH		Roche Holding AG SIX:ROG	11.5	6%	1.9
US		Merck & Co Inc NYSE:MRK	10	3%	3.3
UK		AstraZeneca PLC LSE:AZN	16.1	13%	1.2
CH		Novartis AG SIX:NOVN	13.1	5%	2.6
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.5	1%	7.5
US		Pfizer Inc NYSE:PFE	7.7	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7.2	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
BR		Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3	Average EV/EBIT: 99 7.1	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	29.6	22%	1.3
US		Johnson & Johnson NYSE:JNJ	18.4	6%	3.1
CH		Roche Holding AG SIX:ROG	12.9	6%	2.2
US		Merck & Co Inc NYSE:MRK	12.1	6%	2
UK		AstraZeneca PLC LSE:AZN	22.7	21%	1.1
CH		Novartis AG SIX:NOVN	16.8	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	8.8	2%	4.4
US		Pfizer Inc NYSE:PFE	10.3	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.8	-7%	N/A

Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

OFSA3 Competitors Multiples
Ouro Fino Saude Animal Participacoes SA Competitors

See Also

Company

Help

Tools

Stocks

Ouro Fino Saude Animal Participacoes SA BOVESPA:OFSA3

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

OFSA3 Competitors Multiples Ouro Fino Saude Animal Participacoes SA Competitors

See Also

Company

Help

Tools

Stocks

Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

OFSA3 Competitors Multiples
Ouro Fino Saude Animal Participacoes SA Competitors